Scotiabank Rates American Healthcare REIT (AHR) buy

Scotiabank analyst Nicholas Yulico reaffirmed a Buy rating on American Healthcare REIT, Inc. (NYSE: AHR) on June 18, 2026. The firm set a price target of $51.00 for the stock, suggesting a belief in its steady value as a provider of clinical healthcare real estate. This update follows a series of shifts in the analyst community as they track the company's performance in the senior housing and outpatient medical building sectors.

Analysts Set New Price Targets

While Scotiabank's June 18 report held the line at $51.00, other firms updated their views later in the year. On October 13, 2026, UBS maintained its Buy rating but slightly lowered its target from $63.00 to $62.00. That same day, Barclays also kept an Overweight rating while adjusting its target from $66.00 down to $60.00. Raymond James was more aggressive, initiating coverage with a Strong Buy rating and a $62.00 target on October 13. Earlier, on September 2, 2026, Scotiabank actually lifted its own target to $62.00 from a previous $56.00, showing an evolving perspective on the REIT's potential. Currently, the average target among 15 analysts is $64.40, with a consensus recommendation of Strong Buy.

American Healthcare REIT Stock Trends

On this Thursday, shares of American Healthcare REIT are trading at $48.88. This price places the stock just under its 200-day moving average of $50.88 and noticeably below its 50-day average of $55.23. The stock has seen a 52-week range between $40.00 and $58.70. With a market cap of approximately $11.4 billion, the company is priced at about 76.9 times its trailing earnings, though its forward P/E ratio is lower at 52.8, which is a common way to measure a stock's price against its expected future profits.

Recent Earnings and Financial Health

In its latest financial reporting, American Healthcare REIT posted annual revenue of $2.5 billion. This represents a 24.7% growth rate compared to the prior period. The company maintains a net margin of 4.8% and a return on equity of 3.95%. Investors are looking toward November 5, 2026, for the next quarterly earnings update to see if the company can maintain its current growth trajectory and manage its debt-to-equity ratio of 41.89.

Dividend Income for Shareholders

As a REIT, the company is required to distribute much of its income to investors. It currently pays an annual dividend of $1.00 per share, which provides a dividend yield of 1.92%. The current payout ratio stands at 1.47, a figure that compares the dividend amount to the company's net income.

Insider Buying and Selling at American Healthcare REIT, Inc.

Several insiders were active in the stock on June 24, 2026. Directors Mathieu Streiff, Valerie Richardson, Smith Wilbur III, Marvin O'Quinn, and Dianne Hurley each acquired 2,594 shares. On the same day, Mark Foster, the Executive Vice President and General Counsel, sold 2,500 shares at an average price of $48.58, a transaction totaling $121,450. None of these trades were reported as being part of a Rule 10b5-1 trading plan, which is a tool used by insiders to schedule trades in advance to avoid conflicts of interest.

Healthcare Real Estate Operations

American Healthcare REIT owns a variety of medical properties, including senior housing, skilled nursing facilities, and outpatient buildings. Based in Irvine, California, it manages assets across the United States and the United Kingdom. Because it operates as a REIT, it focuses on generating income from its property portfolio to return to its shareholders. The firm's ability to grow its revenue by nearly 25% shows it is actively expanding its footprint in the healthcare space.

What's Ahead for American Healthcare REIT, Inc.

With the next earnings report scheduled for November 5, 2026, investors will be watching to see if the REIT can hit the targets set by analysts like Nicholas Yulico. While current ratings are largely positive, the stock's recent position below its 50-day moving average suggests it is in a period of consolidation. As with all analyst reports, these ratings are opinions based on past performance and current market data.